Oxford Cannabinoid Technologies is expanding its research and development into oncology.
Epidyolex can now be prescribed on the NHS for epilepsy-related tuberous sclerosis complex (TSC).
The latest issue of the Journal Club explores the benefits of cannabis-based medicines for sleep.
Integro Clinics explores how cannabis could help those living with Avoidant Restrictive Food Intake Disorder (ARFID).
Crohn's and Colitis Awareness Week runs from 1-7 December.
Their exclusion could lead to potentially “dangerous” contraindications
EDS affects different people in different ways and symptoms can range from relatively mild to totally disabling.
Chronic back pain is a frequently overlooked and under-treated symptom of multiple sclerosis (MS) – could cannabis medicines be the answer? Sophie Hayes, specialist cannabis practice nurse at...
UK specialists have reacted to guidance deterring doctors from prescribing cannabis medicines for chronic pain due to a “lack of evidence”. The International Association for the...
A UK medical cannabis company says it can provide products for patients whose supply has been cut off by Brexit, but experts caution that they may...